Price T Rowe Associates Inc Legend Biotech Corp Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
A detailed history of Price T Rowe Associates Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 6,729,779 shares of LEGN stock, worth $266 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,729,779
Previous 6,808,081
1.15%
Holding current value
$266 Million
Previous $222 Million
3.07%
% of portfolio
0.03%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding LEGN
# of Institutions
230Shares Held
74.4MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$273 Million1.21% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$236 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$226 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$148 Million5.57% of portfolio
-
Braidwell LP Stamford, CT2.98MShares$118 Million6.2% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.61B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...